Bio Innovation is
Our Mission
We are developing several biological products for the treatment of unmet needs diseases such as the “diabetic foot infections” and other conditions.
Our goal is to improve the quality of life of all individuals across the globe.
Our Goals
Welcome to Lxbio, where the future of biopharmaceuticals is being redefined. As a newly established pharmaceutical company, we present a compelling opportunity for investors seeking to be at the forefront of groundbreaking innovation in the global biopharmaceutical market.
Invest with us
News
We are thrilled to announce the location of our new state-of-the-art biotechnology manufacturing facility and new R&D site, a significant milestone in our journey towards redefining the landscape of biotechnological innovation.
Last month TechnoPhage, founding partner and shareholder of Lxbio, attended ECCMID 2023. Together with the clinical team from Israel, it was presented the results from two cases of compassionate use carried out in Israel, under the supervision of Dra. Michal Deckel.
Lxbio Pharmaceuticals (Identificar página @Lxbio Pharmaceuticals) is pleased to announce that an investment agreement has been signed with Explorer SCR (Identificar página @Explorer Investments), a leading investment Fund in Portugal, an investment with a global amount of 6 Million Euros, namely, to support Lxbio research & development projects.